Lisinopril
Ace Inhibitors, Plain
Sold as ZESTRIL · ZESTORETIC · ZESTORETIC 10
- Drug class
- Ace Inhibitors, Plain
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 150
- FDA reports (12 mo)
- 10,948
Overview
Plain-language summary, compiled from the cited regulatory records
Lisinopril is a medication classified as an ACE inhibitor [1]. It is approved for the treatment of hypertension, also known as high blood pressure [1]. By lowering blood pressure, lisinopril helps to reduce the risk of serious cardiovascular events, such as strokes and heart attacks [1]. These benefits have been demonstrated in clinical trials involving various types of blood pressure medications [1].
Lisinopril is available under different brand names, including Zestoretic [1]. In the past 12 months, there have been 10,948 adverse event reports associated with this active ingredient [2]. The most frequently reported adverse events include fatigue, off-label use, diarrhea, nausea, and headache [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 92 | May 22, 2026 |
| CA Canada | Health Canada | 33 | January 6, 2026 |
| US United States | FDA | 25 | May 22, 2026 |
GBUnited Kingdom· MHRA
92 products
Uses
Hypertension Treatment of hypertension. Heart failure Treatment of symptomatic heart failure. Acute myocardial infarction Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction.
1).
How to take
CACanada· Health Canada
33 products
Uses
ZESTORETIC (lisinopril and hydrochlorothiazide) is indicated for: • The treatment of essential hypertension in patients for whom combination therapy is appropriate. ZESTORETIC is not indicated for initial therapy (see 4 DOSAGE AND ADMINISTRATION).
Patients in whom lisinopril and diuretic are initiated simultaneously can develop symptomatic hypotension (see 9 DRUG INTERACTIONS). ZESTORETIC is not indicated for the treatment of renovascular hypertension (see 7 WARNINGS AND PRECAUTIONS, Hypotension).
3 Pediatrics). 4 Geriatrics).
How to take
USUnited States· FDA
25 products
Uses
INDICATIONS AND USAGE
Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.
Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Drug interactions
Known interactions involving Lisinopril. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL404960020 · revised April 10, 2026
- [2]Health Canada (DPD) · 02045729 · revised March 22, 2025
- [3]FDA DailyMed · 00b266d9-ac4a-e9… · revised June 29, 2023 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.